UPDATE: Phibro Animal Health (PAHC) Tops Q2 EPS by 6c, Offers FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Phibro Animal Health Corporation Reports Second Quarter Results
February 3, 2020 4:40 PM ESTTEANECK, N.J.--(BUSINESS WIRE)-- Phibro Animal Health Corporation (NASDAQ: PAHC) today announced its financial results for its second quarter ended December 31, 2019.
Highlights for the December 2019 quarter (compared to the December 2018 quarter)
Net sales of $214 million, a decrease of $4 million, or 2% Net income of $12 million, a decrease of $3 million, or 19% Diluted EPS of $0.29, a decrease of $0.07, or 19% Adjusted EBITDA of $29 million, a decrease of $3 million, or... More